Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors

BACKGROUND: Response to immune checkpoint inhibitors (ICIs) is affected by multiple factors. This study aimed to explore whether sites of metastasis are associated with clinical outcomes of ICIs in advanced non-small-cell lung cancer (NSCLC) patients. METHODS: The data of NSCLC patients with high pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jiayi, Gao, Ming, Gou, Qing, Xu, Chongrui, Yan, Honghong, Yang, Mingyi, Li, Jiakang, Yang, Xiaorong, Wei, Xuewu, Zhou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481449/
https://www.ncbi.nlm.nih.gov/pubmed/35869859
http://dx.doi.org/10.1097/CM9.0000000000002217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481449/
https://www.ncbi.nlm.nih.gov/pubmed/35869859
http://dx.doi.org/10.1097/CM9.0000000000002217

Ejemplares similares